| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8757197 | Chinese Medical Sciences Journal | 2016 | 7 Pages |
Abstract
Bevacizumab combined with S-1 was effective and safe for esophageal cancer patients who had recurrent or metastatic diseases after chemoradiation.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ke-ke Nie, Chuan-xin Geng, Ling Zhang, Shi-chao Liu, Zhong-fa Zhang, Rong Wang, Xiao Zou, You-xin Ji,